Skip to Main Content

Author Details

Taehyang Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
2009
13
7
PMIDPaper TitleJournal TitlePublished Year
34986867Hepatocellular carcinoma patients with high circulating cytotoxic T cells and intra-tumoral immune signature benefit from pembrolizumab: results from a single-arm phase 2 trial.Genome Med2022
35899045Acute Surge of Atypical Memory and Plasma B-Cell Subsets Driven by an Extrafollicular Response in Severe COVID-19.Front Cell Infect Microbiol2022
34528562Analysis of intrapatient heterogeneity of circulating tumor cells at the single-cell level in the cerebrospinal fluid of a patient with metastatic gastric cancer.J Cancer Res Ther2021
33846173Determinants of Response and Intrinsic Resistance to PD-1 Blockade in Microsatellite Instability-High Gastric Cancer.Cancer Discov2021
32158697A Pilot Study of Baseline Spatial Genomic Heterogeneity in Primary Gastric Cancers Using Multi-Region Endoscopic Sampling.Front Oncol2020
31315834Tumor Genomic Profiling Guides Patients with Metastatic Gastric Cancer to Targeted Treatment: The VIKTORY Umbrella Trial.Cancer Discov2019
30262818Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy.Nat Genet2018
30271501Antitumor activity of sorafenib plus CDK4/6 inhibitor in pancreatic patient derived cell with KRAS mutation.J Cancer2018
25955569Concentrative nucleoside transporter 3 as a prognostic indicator for favorable outcome of t(8;21)-positive acute myeloid leukemia patients after cytarabine-based chemotherapy.Oncol Rep2015
25830129SOCS1 and SOCS3 are expressed in mononuclear cells in human cytomegalovirus viremia after allogeneic hematopoietic stem cell transplantation.Blood Res2015
23589790Expression of SOCS1 and SOCS3 genes in human graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.Blood Res2013
22627319High TOP2B/TOP2A expression ratio at diagnosis correlates with favourable outcome for standard chemotherapy in acute myeloid leukaemia.Br J Cancer2012
19287976Defective expression of deoxycytidine kinase in cytarabine-resistant acute myeloid leukemia cells.Int J Oncol2009
  • 1 - 13 of 13

Recommended Authors

Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year 2013
Number of shared co-authors 0
Massachusetts Institute of Technology
Career Start Year 2013
Number of shared co-authors 0
Shenzhen Children's Hospital
Career Start Year 2013
Number of shared co-authors 0
and Blood Institute, National Institutes of Health
Career Start Year 2013
Number of shared co-authors 0
Tokyo Medical and Dental University
Career Start Year 2012
Number of shared co-authors 0
Cellworks Group Inc.
Career Start Year 2011
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2011
Number of shared co-authors 0
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2011
Number of shared co-authors 0
Texas Children's Cancer Center
Career Start Year 2010
Number of shared co-authors 0
Universite de Paris, Inserm CIC 1427
Career Start Year 2009
Number of shared co-authors 0
Center for Global Health, School of Public Health, Nanjing Medical University
Career Start Year 2009
Number of shared co-authors 12
City of Hope National Medical Center
Career Start Year 2009
Number of shared co-authors 0
the University of Texas MD Anderson Cancer Center
Career Start Year 2009
Number of shared co-authors 4
The University of Texas MD Anderson Cancer Center
Career Start Year 2008
Number of shared co-authors 0
Georgia Cancer Center, Medical College of Georgia
Career Start Year 2008
Number of shared co-authors 0
Hospital Israelita Albert Einstein
Career Start Year 2007
Number of shared co-authors 0
Institute of Biomedical Science and Children's Hospital, Fudan University
Career Start Year 2006
Number of shared co-authors 0
The University of Texas M. D. Anderson
Career Start Year 2006
Number of shared co-authors 0
Yonsei Cancer Center, Yonsei University College of Medicine
Career Start Year 2005
Number of shared co-authors 3
Huaihe Hospital of Henan University
Career Start Year 2004
Number of shared co-authors 0
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 3
The University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 1
Bloomberg-Kimmel Immunotherapy Institute, Johns Hopkins University School of Medicine
Career Start Year 2001
Number of shared co-authors 1
Division of Clinical Trials and Biostatistics, Mayo Clinic
Career Start Year 2001
Number of shared co-authors 0
School of Clinical Medicine, University of Hong Kong
Career Start Year 1997
Number of shared co-authors 0
The Ohio State University
Career Start Year 1997
Number of shared co-authors 0
University Hospital of Schleswig-Holstein
Career Start Year 1997
Number of shared co-authors 0
Fujian Medical University Cancer Hospital and Fujian Cancer Hospital
Career Start Year 1996
Number of shared co-authors 0
Mayo Clinic
Career Start Year 1995
Number of shared co-authors 0
Center for Cellular Engineering, National Institutes of Health Clinical Center
Career Start Year 1993
Number of shared co-authors 0

Collaborators

Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 7
Busan Paik Hospital, Inje University
Co-authored papers 6
Seoul National University College of Medicine
Co-authored papers 4
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 3
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 3
Korea University, College of Medicine
Co-authored papers 3
Asan Medical Center, University of Ulsan College of Medicine
Co-authored papers 2
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 2
Touro College of Osteopathic Medicine
Co-authored papers 2
Samsung Genome Institute, Samsung Medical Center
Co-authored papers 2
Research Institute, National Cancer Center
Co-authored papers 2
Yonsei University College of Medicine, Republic of Korea S. Biomedics Co.
Co-authored papers 2
Samsung Genome Institute, Samsung Medical Center
Co-authored papers 2
University of Chinese Academy of Sciences
Co-authored papers 1
Samsung Medical Center, Sungkyunkwan University
Co-authored papers 1
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 1
Research Institute of Future Medicine, Samsung Medical Center
Co-authored papers 1
Co-authored papers 1
Inha University
Co-authored papers 1
Yale School of Medicine
Co-authored papers 1
Center for Nanophase Materials Sciences, Oak Ridge National Laboratory
Co-authored papers 1
Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami
Co-authored papers 1
Seoul National University, College of Medicine
Co-authored papers 1
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 1
University of California Riverside
Co-authored papers 1
Samsung Medical Center, Sungkyunkwan University School
Co-authored papers 1
Columbia University
Co-authored papers 1
Merck & Co. Inc.
Co-authored papers 1
Sungkyunkwan University
Co-authored papers 1
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 1